N-alpha-Aminoacyl Colchicines as Promising Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Drug Development

Background:

• Colchicine is a potent anti-cancer agent but suffers from high toxicity.
• Cancer cells' altered amino acid metabolism presents a therapeutic target.
• Developing less toxic colchicine derivatives is a key research objective.

Purpose of the Study:

• To synthesize novel colchicine derivatives incorporating aminoacyl groups.
• To reduce cytotoxicity and enhance selectivity of colchicine analogues.
• To explore new therapeutic strategies for cancer treatment.

Main Methods:

• Synthesis and characterization of 34 colchicine analogues with L- and D-amino acid pendants.
• Assessment of cytotoxicity and antimitotic properties using spectrophotometry and cell cycle assays.
• Evaluation of oncogene downregulation via RTqPCR and in vivo efficacy in SCID mice.

Main Results:

• Synthesized compounds displayed nanomolar antiproliferative activity, generally with lower cytotoxicity than colchicine.
• L-amino acid derivatives were most effective in inhibiting tubulin polymerization, similar to colchicine.
• Compound 6 (Boc-L-proline) showed high selectivity, arrested cells at G2/M phase, downregulated oncogenes (c-Myc, hTERT, VEGF), and exhibited a favorable in vivo toxicity profile (LD50 > 100 mg/kg).

Conclusions:

• Compound 6 represents a promising therapeutic candidate for cancer treatment.
• This novel colchicine derivative offers a reduced toxicity profile compared to the parent drug.
• The findings support the potential of aminoacyl modification for developing safer and more effective anticancer agents.